Nail Changes Secondary to Docetaxel (Taxotere)
Authors:
- C. AzevedoCAC. Azevedo
- E. Pinto FerreiraEFE. Pinto Ferreira
- F. Braga CruzFCF. Braga Cruz
- J. PolóniaJ. Polónia
- 17 June 1999
- journal article
- case report
- Published by S. Karger AG in Dermatology
- Vol. 198 (3) , 288-290
Abstract
Docetaxel is a new taxoid antineoplastic drug widely used for advanced breast cancer. Skin and nail toxicity are one of the more frequent nonhematologic adverse reactions. Besides dark pigmentations and Beau’s lines, subungual hemorrhage, orange discoloration, acute painful paronychia, onycholysis, subungual hyperkeratosis and transverse loss of the nail plate are described. The type of nail alteration is related with the number of cycles administered and there are no efficacious preventive measures to avoid its development. Clinicians should recognize the clinical picture of these adverse nail reactions because docetaxel is used for several neoplastic disorders.Keywords
This publication has 5 references indexed in Scilit:
- Nail Bed Dyschromia Secondary to Docetaxel TherapyArchives of Dermatology, 1998
- 5-Fluorouracil and mitomycin-C in colorectal cancer: Unacceptable conclusionAnnals of Oncology, 1998
- Acute cutaneous reactions to docetaxel, a new chemotherapeutic agentArchives of Dermatology, 1995
- Transverse white lines in the fingernails induced by combination chemotherapyArchives of Dermatology, 1993
- Acute paronychia after high-dose methotrexate therapyArchives of Dermatology, 1983